Review Article
Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review
Chinese Clinical Oncology
2022;
11
(4)
:26
.
(31 August 2022)
The challenging surgical management of hepatic epithelioid hemangioendothelioma: a narrative review
Chinese Clinical Oncology
2022;
11
(4)
:27
.
(31 August 2022)
Non-colorectal non-neuroendocrine liver metastasis: a narrative review of surgical treatment
Chinese Clinical Oncology
2022;
11
(4)
:28
.
(31 August 2022)
A narrative review on the management of glioblastoma in China
Chinese Clinical Oncology
2022;
11
(4)
:29
.
(31 August 2022)
Measuring response to neoadjuvant therapy using biomarkers in pancreatic cancer: a narrative review
Chinese Clinical Oncology
2022;
11
(4)
:30
.
(31 August 2022)
Original Article
Progression of citation-based scholarly activity from postgraduate year one to postgraduate year two in a current resident class
Chinese Clinical Oncology
2022;
11
(4)
:31
.
(31 August 2022)
Interviews with Outstanding Guest Editors1
Interview with Prof. Savio George Barreto: pancreatic cancer—an old problem needs a fresh perspective
Chinese Clinical Oncology
2022;
11
(4)
:32
.
(31 August 2022)
Interview with Prof. Rimas V. Lukas: discussion with an academic neuro-oncologist
Chinese Clinical Oncology
2022;
11
(4)
:33
.
(31 August 2022)
Disclosure:
1. The series “Interviews with Outstanding Guest Editors” was commissioned by the editorial office, Chinese Clinical Oncology without any funding or sponsorship.
